ISCALIMAB

UNII:	0628T707D0
Formula:
Preferred Substance Name:	ISCALIMAB

2031153-61-2
CFZ533
CFZ-533
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD40 ANTIGEN),(HUMAN MONOCLONAL CLONE NVS240705 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CLONE NVS240705 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 5 (B-CELL SURFACE ANTIGEN CD40))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-450) (HOMO SAPIENS VH (IGHV3-30*03 (94%) (IGHD)-IGHJ4*01) (8.8.13) (1-120)-HOMO SAPIENS IGHG1*03 (CH2(N67>A(300))) (121-450)) (223-219')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-219') (HOMO SAPIENS V-KAPPA (IGKV2-28*01 (95%) IGKJ3*01 (92%))(11.3.9) (1'-112')-HOMO SAPIENS IGKC*01 (113'-219')), DIMER (229-229'':232-232'')-BISDISULFIDE
ISCALIMAB [INN]
ISCALIMAB [USAN]
ISCALIMAB [WHO-DD]
NVP-CFZ533

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ISCALIMAB

Synonyms and Mappings

Resources